Detection of occult liver metastases in colorectal cancer by measurement of biliary carcinoembryonic antigen

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2743-2746

  Novell, F ^a,b   Trias, M ^a   Molina, R ^a   Filella, X ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE   (Spain)

Author keywords

CEA bile levels; Colorectal carcinoma; Liver metastases

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTICLE; BILE LEVEL; BLOOD LEVEL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BILE; CARCINOEMBRYONIC ANTIGEN; CARCINOMA; CHOLELITHIASIS; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 0030820559     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Finlay IG, McArdle CS: Occult hepatic metastases in colorectal carcinoma. Br J Surg 73: 732-735, 1986.
2. Steele G, Ellenverg S, Ramming K, et al: CEA monitoring among patients in multi-institutional adjuvant G.I. therapy protocols. Ann Surg 196: 162-169, 1982.
3. Yeatman TJ, Bland KJ, Copeland EM, et al: Relationship (between colorectal liver metastases and CEA levels in gallbladder bile. Ann Surg 210-505-512, 1989.
4. Stone MD, Cady B, Jenkins RL, et al: Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg 125: 718-721, 1990.
5. Hughes KS, Rossi RL: Colorectal cancer metastat liver. Resection. In: Cameron J (ed): Current Surgical Therapy, ed 4 St Louis, Mosby-Year Book, 1992, pp 1-5.
6. Lise M, Da Pian PPI Nitti D, et al: Colorectal metastases to the liver: Present status of management. Dis Colon Rectum 33: 688-694, 1990.
7. Machi J, Isomoto H, Kurohiji T, et al: Accuracy of intraoperative ultrasonography in diagnosing liver metastases from colorectal cancer: evaluation with postoperative followup results. World J Surg 15: 551-557, 1991.
8. Chu DZ, Erickson CA, Rusell MP, et al: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg 126: 314- 316, 1991.
9. Moertel CG, O'Fallon JR, Go VLW, et al: The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer 58: 603-610, 1986.
10. Moertel WF, Greig JD, Seth J, Sturgeon C, Nixon SJ: Raised carcinoembryonic antigen level as an indicator of recurrent disease in follow-up of patients with colorectal cancer. Br J Gen Pract 45: 282- 283, 1995.
11. Yeatman TJ, Kimura AK, Copeland EM, Bland KL: Rapid analysis of carcinoembryonic antigen levels in gallblader bite; identification of patients for high risk for colorectal liver metastasis. Ann Surg 213: 113-117, 1990.
12. Paganuzzi M, Onetto M, de Paoli M, Castagnola M, de Salvo L, Civalleri D, Grossi CE: Carcinoembryonic antigen in serum and bile of colorectal cancer patients with or without detectable liver metastases. Anticancer Res 14: 1409-1412, 1994.
13. Ishida H, Hojo I, Gonda T, Nakajima H, Hirukawa H, Itoh M, Satoh K, Higuchi T, Toyooka M, Yoshimaga K: Measurement of bile CEA levels in patients with colorectal cancer : is it of value for diagnosis of occult liver metastases aiming at prophylactic colorectal regional hepatic chemotherapy ?, Gan to Kagaku Tyoho 20: 1551-1554, 1993.
14. Frikart L, Fournier K, Mach JP, Givel JC: Potential value of biliary CEA assay in early detection of colorectal adenocarcinoma liver metastases. Eur J Surg Oncol 21: 276-279, 1995.
15. Paul MA, Visier JJ, Mulder C, Blomjous JGAM, van Kamp GJ, Cuesta MA, Meijer S: Detection of occult liver metastases by measurement of biliary carcinoembryonic antigen concentrations. Eur J Surg 162:483-488, 1996.
16. Lamerz R, Meyer G, Heiss M, Brandt A, Vogel S, Jauch KW: Gallbladder and serum CEA in cholecystolithiasis and malignant gastrointestinal diseases. In: Tumor associated antigens, oncogenes, receptors, cytokines in tumor diagnosis and therapy at the beginning of the ninetis (Klapdor R, ed). Munchen, Zuckschwerdt Verlag. 1992, pp 23-27.
17. Hinoda Y, Neumaier M, Hefta S, et al: Molecular cloning of a cDNA coding biliary giycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen. Proc Natl Acad Sci USA 85: 6959-6963, 1985.
18. Woolfson K. Tumor markers in cancer of the colon and rectum. Dis Colon Rectum 34: 506-511, 1991.
19. Tatsuta M, Yamamura H, Yamamoto R, et al: Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer. Cancer 50: 2903-2909, 1982.
20. Ohshio G, Manabe T, Watanabe Y, et al: Comparative studies of DUPAN-2 carcinoembryonic antigen, and CA 19.9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation on the influence of obstructive jaundice. Am J Gastroenterol 85: 1370-1376, 1990.
21. Uchino R, Kanemitsu K, Obayashi H, Hiraoka T, Miyauchi Y: Carcinoembryonic antigen and CEA-related substances in the bile of patients with biliary diseases. Am J Surg 167: 306-308, 1994.
22. Nakeeb A, Lipstt PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA: Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 171: 147-152, 1996.